ERS Publications Podcasts

As part of the February issue, the European Respiratory Journal presents the latest in its series of podcasts. Deputy Chief Editor Don Sin interviews David Halpin (University of Exeter Medical School, Faculty of Health and Life Sciences, University of Exeter, Exeter, UK) about his Viewpoint editorial on a shared vision from the Global Initiative for Chronic Obstructive Lung Disease and the Global Initiative for Asthma of how to address the global challenges of COPD and asthma, published in this issue of the ERJ (https://doi.org/10.1183/13993003.02244-2025).

Cite this podcast as: ERJ Podcast February 2026: Addressing the global challenges of COPD and asthma. Eur Respir J 2026; 67: 26E6702 [https://doi.org/10.1183/13993003.E6702-2026].

"Even now, many patients remain misunderstood and mislabelled by their clinician and their family, and even by our society."

In this instalment of the ERS Monograph podcast, Guido Marchi (Early Career Member representative for the Monograph) meets with the Guest Editors of Chronic Cough: Woo-Jung Song, Lorcan McGarvey, Peter S.P. Cho and Kian Fan Chung. They reflect on the way in which chronic cough has evolved from being just a symptom of other diseases to an independent condition recognised for its complexity. In a lively and informative discussion, they cover topics such as antitussive development, the key tools and methods of chronic cough assessment, and the importance of a multidisciplinary team in the cough clinic.

As part of the January issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief Editor James Chalmers interviews editorial board member Janice Leung about the clinical, physiological, imaging and molecular responses to cannabis smoking seen in the Canadian Users of Cannabis Smoke study published in this issue of the ERJ (https://doi.org/10.1183/13993003.01659-2025).

Cite this podcast as: ERJ Podcast January 2026: Cannabis and the lung. Eur Respir J 2026; 67: 26E6701 [https://doi.org/10.1183/13993003.E6701-2026].

As part of the December issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief Editor James Chalmers and Deputy Chief Editor Don Sin for their end-of-year roundup of their highlights from the ERJ in 2025.

Cite this podcast as: ERJ Podcast December 2025: Year in review. Eur Respir J 2025; 66: 25E6606. [doi.org/10.1183/13993003.E6606-2025]

As part of the November issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief Editor James Chalmers, Deputy Chief Editor Don Sin and European Respiratory Review Chief Editor Rory Morty discuss the merits and pitfalls of the rapidly increasing use of generative AI in scientific publishing.

Cite this podcast as: ERJ Podcast November 2025: Artificial intelligence in publishing. Eur Respir J 2025; 66: 25E6605. [doi.org/10.1183/13993003.E6605-2025]

As part of the October issue, the European Respiratory Journal presents the latest in its series of podcasts. Deputy Chief Editor Don Sin interviews Section Editor Isabella Annesi-Maesano about natural disasters and respiratory health, as discussed in her review article in this issue of the ERJ: https://doi.org/10.1183/13993003.02563-2024

Cite this podcast as: ERJ Podcast October 2025: Natural disasters and respiratory health. Eur Respir J 2025; 66: 25E6604 [https://doi.org/10.1183/13993003.E6604-2025]

"Although we have learned a lot about this disease [...] we still need to improve awareness. That means colleagues have to think that the patient may have pulmonary hypertension."

In this episode, Dorina Esendagli (the Monograph's Early Career Member representative) meets with Gabor Kovacs to discuss the recent Monograph on "Pulmonary Hypertension", which he co-Guest Edited with Athénaïs Boucly and Robin Condliffe. Gabor explains how the Monograph addresses diagnosis and can be used to guide the nonspecialist, highlights the importance of the multidisciplinary team, and brings important areas of future research into focus.

As part of the September issue, the European Respiratory Journal presents the latest in its series of podcasts. Deputy Chief Editor Don Sin interviews Associate Editor Marcus Mall about neutrophil-derived biomarkers in bronchiectasis, as discussed in his review article in this issue of the ERJ: https://doi.org/10.1183/13993003.00081-2025

Correction: At 5 min 54 s in this podcast, in response to a question from D. Sin regarding the dosing of azithromycin, M. Mall mistakenly replied that “For the immunomodulatory effects, it would be a standard long-term therapy with a three times per day regimen.” He meant to say “three times per week”. We apologise for this error.

Cite this podcast as: ERJ Podcast September 2025: Neutrophil-derived biomarkers in bronchiectasis. Eur Respir J 2025; 55: 25E6603. [https://doi.org/10.1183/13993003.E6603-2025]

As part of the August issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief Editor James Chalmers interviews Winfried Randerath (Bethanien Hospital, Clinic of Pneumology and Allergology, Centre for Sleep Medicine and Respiratory Care, Institute of Pneumology at the University of Cologne, Solingen, Germany) about the European Respiratory Society and European Sleep Research Society statement on the treatment of central sleep apnoea with adaptive servo-ventilation in this issue of the ERJ: https://doi.org/10.1183/13993003.00263-2025

Cite this podcast as: ERJ Podcast August 2025: Treatment of central sleep apnoea with adaptive servo-ventilation. Eur Respir J 2025; 66: 25E6602 [doi.org/10.1183/13993003.E6602-2025].

“We really need to celebrate the exciting times in asthma but also focus on the advocacy for improving outcomes in research and in clinical practice”

Leading asthma experts David Jackson, Vanessa McDonald and Ian Pavord meet with Monograph Editorial Board member Dorina Esendagli to discuss their 500-page authoritative guide to the latest developments in the field. They discuss pathophysiology, treatable traits, biomarkers, comorbidities, the importance of the multidisciplinary team, and the personal experiences that gave them a genuine passion for helping asthma patients.